EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $797,142 | -30.8% | 50,548 | -14.6% | 0.01% | -27.3% |
| Q2 2023 | $1,151,120 | -14.8% | 59,214 | +24.3% | 0.01% | -21.4% |
| Q1 2023 | $1,351,320 | +31.4% | 47,632 | +35.3% | 0.01% | +27.3% |
| Q4 2022 | $1,028,750 | +63.0% | 35,195 | +47.4% | 0.01% | +57.1% |
| Q3 2022 | $631,000 | -53.3% | 23,875 | -21.5% | 0.01% | -50.0% |
| Q2 2022 | $1,352,000 | -25.4% | 30,425 | -16.9% | 0.01% | -6.7% |
| Q1 2022 | $1,812,000 | +90.9% | 36,622 | +96.4% | 0.02% | +114.3% |
| Q4 2021 | $949,000 | +2.0% | 18,644 | +11.8% | 0.01% | 0.0% |
| Q3 2021 | $930,000 | +37.6% | 16,680 | +5.6% | 0.01% | +40.0% |
| Q2 2021 | $676,000 | +7.6% | 15,798 | +4.9% | 0.01% | +25.0% |
| Q1 2021 | $628,000 | +6.6% | 15,056 | +19.0% | 0.00% | -20.0% |
| Q4 2020 | $589,000 | +9.1% | 12,654 | -0.5% | 0.01% | -16.7% |
| Q3 2020 | $540,000 | -70.2% | 12,719 | -66.3% | 0.01% | -70.0% |
| Q2 2020 | $1,812,000 | -23.7% | 37,765 | -26.9% | 0.02% | -37.5% |
| Q1 2020 | $2,376,000 | -20.9% | 51,647 | +3.3% | 0.03% | +18.5% |
| Q4 2019 | $3,003,000 | -9.7% | 49,986 | -14.9% | 0.03% | -12.9% |
| Q3 2019 | $3,324,000 | -11.7% | 58,767 | -13.1% | 0.03% | -8.8% |
| Q2 2019 | $3,766,000 | +15.7% | 67,633 | +4.9% | 0.03% | +21.4% |
| Q1 2019 | $3,256,000 | +117.6% | 64,483 | +73.6% | 0.03% | +115.4% |
| Q4 2018 | $1,496,000 | -47.4% | 37,139 | -9.5% | 0.01% | -35.0% |
| Q3 2018 | $2,845,000 | -6.6% | 41,033 | +1.9% | 0.02% | -4.8% |
| Q2 2018 | $3,047,000 | -17.4% | 40,275 | -42.5% | 0.02% | -19.2% |
| Q1 2018 | $3,691,000 | -24.3% | 70,043 | -23.3% | 0.03% | -18.8% |
| Q4 2017 | $4,879,000 | +20.4% | 91,334 | +34.5% | 0.03% | +18.5% |
| Q3 2017 | $4,051,000 | – | 67,916 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |